PubMed:7540078
Annnotations
Glycan-Motif
{"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":457,"end":460},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T2","span":{"begin":457,"end":460},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T3","span":{"begin":919,"end":923},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T4","span":{"begin":919,"end":923},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T5","span":{"begin":1031,"end":1037},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T6","span":{"begin":1038,"end":1042},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T7","span":{"begin":1038,"end":1042},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T8","span":{"begin":1091,"end":1097},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T9","span":{"begin":1145,"end":1151},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T10","span":{"begin":1255,"end":1258},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T11","span":{"begin":1255,"end":1258},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T12","span":{"begin":1375,"end":1381},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T13","span":{"begin":1382,"end":1385},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T14","span":{"begin":1382,"end":1385},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T15","span":{"begin":1423,"end":1429},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T16","span":{"begin":1496,"end":1500},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T17","span":{"begin":1496,"end":1500},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T18","span":{"begin":1510,"end":1516},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T19","span":{"begin":1517,"end":1521},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T20","span":{"begin":1517,"end":1521},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T21","span":{"begin":1584,"end":1587},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T22","span":{"begin":1584,"end":1587},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T23","span":{"begin":1603,"end":1609},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T24","span":{"begin":1610,"end":1613},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T25","span":{"begin":1610,"end":1613},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T26","span":{"begin":1687,"end":1690},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T27","span":{"begin":1687,"end":1690},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos6-Glycan-Motif-Image
{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":457,"end":460},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":919,"end":923},"obj":"Glycan_Motif"},{"id":"T5","span":{"begin":1031,"end":1037},"obj":"Glycan_Motif"},{"id":"T6","span":{"begin":1038,"end":1042},"obj":"Glycan_Motif"},{"id":"T8","span":{"begin":1091,"end":1097},"obj":"Glycan_Motif"},{"id":"T9","span":{"begin":1145,"end":1151},"obj":"Glycan_Motif"},{"id":"T10","span":{"begin":1255,"end":1258},"obj":"Glycan_Motif"},{"id":"T12","span":{"begin":1375,"end":1381},"obj":"Glycan_Motif"},{"id":"T13","span":{"begin":1382,"end":1385},"obj":"Glycan_Motif"},{"id":"T15","span":{"begin":1423,"end":1429},"obj":"Glycan_Motif"},{"id":"T16","span":{"begin":1496,"end":1500},"obj":"Glycan_Motif"},{"id":"T18","span":{"begin":1510,"end":1516},"obj":"Glycan_Motif"},{"id":"T19","span":{"begin":1517,"end":1521},"obj":"Glycan_Motif"},{"id":"T21","span":{"begin":1584,"end":1587},"obj":"Glycan_Motif"},{"id":"T23","span":{"begin":1603,"end":1609},"obj":"Glycan_Motif"},{"id":"T24","span":{"begin":1610,"end":1613},"obj":"Glycan_Motif"},{"id":"T26","span":{"begin":1687,"end":1690},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC"},{"id":"A4","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE"},{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A6","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC"},{"id":"A7","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE"},{"id":"A8","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A9","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A10","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81983KG"},{"id":"A11","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G24638PB"},{"id":"A12","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A13","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81983KG"},{"id":"A14","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G24638PB"},{"id":"A15","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A16","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC"},{"id":"A17","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE"},{"id":"A18","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A19","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC"},{"id":"A20","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE"},{"id":"A21","pred":"image","subj":"T21","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81983KG"},{"id":"A22","pred":"image","subj":"T21","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G24638PB"},{"id":"A23","pred":"image","subj":"T23","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A24","pred":"image","subj":"T24","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81983KG"},{"id":"A25","pred":"image","subj":"T24","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G24638PB"},{"id":"A26","pred":"image","subj":"T26","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK"},{"id":"A27","pred":"image","subj":"T26","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
Glycosmos6-GlycoEpitope
{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":919,"end":923},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"T2","span":{"begin":1038,"end":1042},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"T3","span":{"begin":1496,"end":1500},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"T4","span":{"begin":1517,"end":1521},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos6-Glycan-Motif-Structure
{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":457,"end":460},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T2","span":{"begin":457,"end":460},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"},{"id":"T3","span":{"begin":919,"end":923},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T4","span":{"begin":919,"end":923},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T5","span":{"begin":1031,"end":1037},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T6","span":{"begin":1038,"end":1042},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T7","span":{"begin":1038,"end":1042},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T8","span":{"begin":1091,"end":1097},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T9","span":{"begin":1145,"end":1151},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T10","span":{"begin":1255,"end":1258},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T11","span":{"begin":1255,"end":1258},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T12","span":{"begin":1375,"end":1381},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T13","span":{"begin":1382,"end":1385},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T14","span":{"begin":1382,"end":1385},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T15","span":{"begin":1423,"end":1429},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T16","span":{"begin":1496,"end":1500},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T17","span":{"begin":1496,"end":1500},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T18","span":{"begin":1510,"end":1516},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T19","span":{"begin":1517,"end":1521},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T20","span":{"begin":1517,"end":1521},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"},{"id":"T21","span":{"begin":1584,"end":1587},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T22","span":{"begin":1584,"end":1587},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T23","span":{"begin":1603,"end":1609},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T24","span":{"begin":1610,"end":1613},"obj":"https://glytoucan.org/Structures/Glycans/G24638PB"},{"id":"T25","span":{"begin":1610,"end":1613},"obj":"https://glytoucan.org/Structures/Glycans/G81983KG"},{"id":"T26","span":{"begin":1687,"end":1690},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T27","span":{"begin":1687,"end":1690},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
Glycosmos6-MAT
{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"T2","span":{"begin":265,"end":271},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"T3","span":{"begin":445,"end":450},"obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"T4","span":{"begin":445,"end":450},"obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"T5","span":{"begin":550,"end":556},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"T6","span":{"begin":704,"end":709},"obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"T7","span":{"begin":704,"end":709},"obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"T8","span":{"begin":753,"end":759},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T1","span":{"begin":22,"end":34},"obj":"FMAID:82816"},{"id":"_T2","span":{"begin":22,"end":34},"obj":"FMAID:196811"},{"id":"_T3","span":{"begin":52,"end":58},"obj":"FMAID:93688"},{"id":"_T4","span":{"begin":52,"end":58},"obj":"FMAID:7210"},{"id":"_T5","span":{"begin":194,"end":228},"obj":"FMAID:196810"},{"id":"_T6","span":{"begin":194,"end":228},"obj":"FMAID:82815"},{"id":"_T7","span":{"begin":210,"end":228},"obj":"FMAID:196809"},{"id":"_T8","span":{"begin":210,"end":228},"obj":"FMAID:196806"},{"id":"_T9","span":{"begin":210,"end":228},"obj":"FMAID:82811"},{"id":"_T10","span":{"begin":210,"end":228},"obj":"FMAID:196808"},{"id":"_T11","span":{"begin":210,"end":228},"obj":"FMAID:82813"},{"id":"_T12","span":{"begin":210,"end":228},"obj":"FMAID:196813"},{"id":"_T13","span":{"begin":210,"end":228},"obj":"FMAID:82818"},{"id":"_T14","span":{"begin":210,"end":228},"obj":"FMAID:196815"},{"id":"_T15","span":{"begin":210,"end":228},"obj":"FMAID:82819"},{"id":"_T16","span":{"begin":210,"end":228},"obj":"FMAID:196814"},{"id":"_T17","span":{"begin":210,"end":228},"obj":"FMAID:196807"},{"id":"_T18","span":{"begin":210,"end":228},"obj":"FMAID:82812"},{"id":"_T19","span":{"begin":210,"end":228},"obj":"FMAID:82814"},{"id":"_T20","span":{"begin":210,"end":228},"obj":"FMAID:82817"},{"id":"_T21","span":{"begin":210,"end":228},"obj":"FMAID:196812"},{"id":"_T22","span":{"begin":234,"end":246},"obj":"FMAID:82816"},{"id":"_T23","span":{"begin":234,"end":246},"obj":"FMAID:196811"},{"id":"_T24","span":{"begin":265,"end":271},"obj":"FMAID:7210"},{"id":"_T25","span":{"begin":265,"end":271},"obj":"FMAID:93688"},{"id":"_T26","span":{"begin":326,"end":334},"obj":"FMAID:167180"},{"id":"_T27","span":{"begin":417,"end":428},"obj":"FMAID:196811"},{"id":"_T28","span":{"begin":417,"end":428},"obj":"FMAID:82816"},{"id":"_T29","span":{"begin":445,"end":450},"obj":"FMAID:165280"},{"id":"_T30","span":{"begin":550,"end":556},"obj":"FMAID:93688"},{"id":"_T31","span":{"begin":550,"end":556},"obj":"FMAID:7210"},{"id":"_T32","span":{"begin":628,"end":640},"obj":"FMAID:196811"},{"id":"_T33","span":{"begin":628,"end":640},"obj":"FMAID:82816"},{"id":"_T34","span":{"begin":704,"end":709},"obj":"FMAID:165280"},{"id":"_T35","span":{"begin":753,"end":759},"obj":"FMAID:93688"},{"id":"_T36","span":{"begin":753,"end":759},"obj":"FMAID:7210"},{"id":"_T37","span":{"begin":826,"end":838},"obj":"FMAID:82816"},{"id":"_T38","span":{"begin":826,"end":838},"obj":"FMAID:196811"},{"id":"_T39","span":{"begin":1772,"end":1782},"obj":"FMAID:196726"},{"id":"_T40","span":{"begin":1772,"end":1782},"obj":"FMAID:82738"},{"id":"_T41","span":{"begin":1796,"end":1808},"obj":"FMAID:196811"},{"id":"_T42","span":{"begin":1796,"end":1808},"obj":"FMAID:82816"},{"id":"_T43","span":{"begin":1946,"end":1956},"obj":"FMAID:196726"},{"id":"_T44","span":{"begin":1946,"end":1956},"obj":"FMAID:82738"},{"id":"_T45","span":{"begin":1991,"end":2003},"obj":"FMAID:196811"},{"id":"_T46","span":{"begin":1991,"end":2003},"obj":"FMAID:82816"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
uniprot-human
{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":387,"end":393},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T2","span":{"begin":481,"end":487},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T3","span":{"begin":495,"end":501},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T4","span":{"begin":944,"end":950},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T5","span":{"begin":961,"end":967},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T6","span":{"begin":992,"end":998},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T7","span":{"begin":1006,"end":1012},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T8","span":{"begin":1063,"end":1069},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T9","span":{"begin":1080,"end":1086},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T10","span":{"begin":1114,"end":1120},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T11","span":{"begin":1128,"end":1134},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T12","span":{"begin":1167,"end":1173},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T13","span":{"begin":1184,"end":1190},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T14","span":{"begin":1215,"end":1221},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T15","span":{"begin":1229,"end":1235},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T16","span":{"begin":1285,"end":1291},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T17","span":{"begin":1319,"end":1325},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T18","span":{"begin":1333,"end":1339},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T19","span":{"begin":1347,"end":1353},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T20","span":{"begin":1412,"end":1418},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T21","span":{"begin":1449,"end":1455},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T22","span":{"begin":1463,"end":1469},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T23","span":{"begin":1477,"end":1483},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T24","span":{"begin":1021,"end":1023},"obj":"http://www.uniprot.org/uniprot/Q8SNA0"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
uniprot-mouse
{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":1021,"end":1023},"obj":"http://www.uniprot.org/uniprot/P04441"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlycoBiology-NCBITAXON
{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":186,"end":193},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/604139"},{"id":"T2","span":{"begin":315,"end":325},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/608684"},{"id":"T3","span":{"begin":387,"end":391},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T4","span":{"begin":387,"end":391},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T5","span":{"begin":481,"end":485},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T6","span":{"begin":481,"end":485},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T7","span":{"begin":495,"end":499},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T8","span":{"begin":495,"end":499},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T9","span":{"begin":944,"end":948},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T10","span":{"begin":944,"end":948},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T11","span":{"begin":961,"end":965},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T12","span":{"begin":961,"end":965},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T13","span":{"begin":992,"end":996},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T14","span":{"begin":992,"end":996},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T15","span":{"begin":1006,"end":1010},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T16","span":{"begin":1006,"end":1010},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T17","span":{"begin":1063,"end":1067},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T18","span":{"begin":1063,"end":1067},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T19","span":{"begin":1080,"end":1084},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T20","span":{"begin":1080,"end":1084},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T21","span":{"begin":1114,"end":1118},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T22","span":{"begin":1114,"end":1118},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T23","span":{"begin":1128,"end":1132},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T24","span":{"begin":1128,"end":1132},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T25","span":{"begin":1167,"end":1171},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T26","span":{"begin":1167,"end":1171},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T27","span":{"begin":1184,"end":1188},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T28","span":{"begin":1184,"end":1188},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T29","span":{"begin":1215,"end":1219},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T30","span":{"begin":1215,"end":1219},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T31","span":{"begin":1229,"end":1233},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T32","span":{"begin":1229,"end":1233},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T33","span":{"begin":1285,"end":1289},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T34","span":{"begin":1285,"end":1289},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T35","span":{"begin":1319,"end":1323},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T36","span":{"begin":1319,"end":1323},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T37","span":{"begin":1333,"end":1337},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T38","span":{"begin":1333,"end":1337},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T39","span":{"begin":1347,"end":1351},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T40","span":{"begin":1347,"end":1351},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T41","span":{"begin":1412,"end":1416},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T42","span":{"begin":1412,"end":1416},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T43","span":{"begin":1449,"end":1453},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T44","span":{"begin":1449,"end":1453},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T45","span":{"begin":1463,"end":1467},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T46","span":{"begin":1463,"end":1467},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T47","span":{"begin":1477,"end":1481},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T48","span":{"begin":1477,"end":1481},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T49","span":{"begin":1647,"end":1653},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/23017"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":66,"end":81},"obj":"http://purl.obolibrary.org/obo/GO_0007283"},{"id":"T2","span":{"begin":279,"end":294},"obj":"http://purl.obolibrary.org/obo/GO_0007283"},{"id":"T3","span":{"begin":781,"end":796},"obj":"http://purl.obolibrary.org/obo/GO_0007283"},{"id":"T4","span":{"begin":1558,"end":1573},"obj":"http://purl.obolibrary.org/obo/GO_0007283"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GO-MF
{"project":"GO-MF","denotations":[{"id":"T1","span":{"begin":326,"end":334},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T2","span":{"begin":265,"end":271},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T3","span":{"begin":550,"end":556},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T4","span":{"begin":753,"end":759},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlycoBiology-MAT
{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"T2","span":{"begin":265,"end":271},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"T3","span":{"begin":445,"end":450},"obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"T4","span":{"begin":445,"end":450},"obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"T5","span":{"begin":550,"end":556},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"T6","span":{"begin":704,"end":709},"obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"T7","span":{"begin":704,"end":709},"obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"T8","span":{"begin":753,"end":759},"obj":"http://purl.obolibrary.org/obo/MAT_0000132"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyTouCan-IUPAC
{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T2","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T3","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T4","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T5","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T6","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T7","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T8","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T9","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T10","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T11","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T12","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T13","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T14","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T15","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T16","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T17","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T18","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T19","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T20","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T21","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T22","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T23","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T24","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T25","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T26","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G60454LU\""},{"id":"GlycanIUPAC_T27","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T28","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T29","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T30","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T31","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T32","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T33","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T34","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T35","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T36","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T37","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T38","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T39","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T40","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T41","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T42","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T43","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T44","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T45","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T46","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T47","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T48","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T49","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T50","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T51","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T52","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G61700OH\""},{"id":"GlycanIUPAC_T53","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T54","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T55","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T56","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T57","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T58","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T59","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T60","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T61","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T62","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T63","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T64","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T65","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T66","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T67","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T68","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T69","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T70","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T71","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T72","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T73","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T74","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T75","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T76","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T77","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T78","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G91438TH\""},{"id":"GlycanIUPAC_T79","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T80","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T81","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T82","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T83","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T84","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T85","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T86","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T87","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T88","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T89","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T90","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T91","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T92","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T93","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T94","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T95","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T96","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T97","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T98","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T99","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T100","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T101","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T102","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T103","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T104","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G22917YC\""},{"id":"GlycanIUPAC_T105","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T106","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T107","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T108","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T109","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T110","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T111","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T112","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T113","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T114","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T115","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T116","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T117","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T118","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T119","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T120","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T121","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T122","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T123","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T124","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T125","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T126","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T127","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T128","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T129","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T130","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G76286GK\""},{"id":"GlycanIUPAC_T131","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T132","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T133","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T134","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T135","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T136","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T137","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T138","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T139","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T140","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T141","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T142","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T143","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T144","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T145","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T146","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T147","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T148","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T149","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T150","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T151","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T152","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T153","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T154","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T155","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T156","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G14736OO\""},{"id":"GlycanIUPAC_T157","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T158","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T159","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T160","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T161","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T162","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T163","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T164","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T165","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T166","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T167","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T168","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T169","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T170","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T171","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T172","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T173","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T174","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T175","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T176","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T177","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T178","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T179","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T180","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T181","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T182","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G52334CZ\""},{"id":"GlycanIUPAC_T183","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T184","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T185","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T186","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T187","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T188","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T189","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T190","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T191","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T192","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T193","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T194","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T195","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T196","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T197","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T198","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T199","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T200","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T201","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T202","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T203","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T204","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T205","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T206","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T207","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T208","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G65205KJ\""},{"id":"GlycanIUPAC_T209","span":{"begin":18,"end":21},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T210","span":{"begin":230,"end":233},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T211","span":{"begin":368,"end":371},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T212","span":{"begin":413,"end":416},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T213","span":{"begin":453,"end":456},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T214","span":{"begin":462,"end":465},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T215","span":{"begin":624,"end":627},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T216","span":{"begin":822,"end":825},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T217","span":{"begin":915,"end":918},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T218","span":{"begin":925,"end":928},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T219","span":{"begin":972,"end":975},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T220","span":{"begin":1026,"end":1029},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T221","span":{"begin":1044,"end":1047},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T222","span":{"begin":1195,"end":1198},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T223","span":{"begin":1250,"end":1253},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T224","span":{"begin":1266,"end":1269},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T225","span":{"begin":1296,"end":1299},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T226","span":{"begin":1371,"end":1374},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T227","span":{"begin":1393,"end":1396},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T228","span":{"begin":1492,"end":1495},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T229","span":{"begin":1506,"end":1509},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T230","span":{"begin":1580,"end":1583},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T231","span":{"begin":1599,"end":1602},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T232","span":{"begin":1683,"end":1686},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T233","span":{"begin":1792,"end":1795},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T234","span":{"begin":1987,"end":1990},"obj":"\"http://rdf.glycoinfo.org/glycan/G96046UH\""},{"id":"GlycanIUPAC_T235","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G41652MJ\""},{"id":"GlycanIUPAC_T236","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G20761YC\""},{"id":"GlycanIUPAC_T237","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G19807HM\""},{"id":"GlycanIUPAC_T238","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G20351TE\""},{"id":"GlycanIUPAC_T239","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G71957MR\""},{"id":"GlycanIUPAC_T240","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G59040AE\""},{"id":"GlycanIUPAC_T241","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G14987PW\""},{"id":"GlycanIUPAC_T242","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G95064PC\""},{"id":"GlycanIUPAC_T243","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G39143AQ\""},{"id":"GlycanIUPAC_T244","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G65149OO\""},{"id":"GlycanIUPAC_T245","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G02766SY\""},{"id":"GlycanIUPAC_T246","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G26019KJ\""},{"id":"GlycanIUPAC_T247","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G36429CZ\""},{"id":"GlycanIUPAC_T248","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G89633TP\""},{"id":"GlycanIUPAC_T249","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G28494FO\""},{"id":"GlycanIUPAC_T250","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G06219CP\""},{"id":"GlycanIUPAC_T251","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G44237SM\""},{"id":"GlycanIUPAC_T252","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G57948RL\""},{"id":"GlycanIUPAC_T253","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G64016DN\""},{"id":"GlycanIUPAC_T254","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G14536PC\""},{"id":"GlycanIUPAC_T255","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G14356FW\""},{"id":"GlycanIUPAC_T256","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G34565UO\""},{"id":"GlycanIUPAC_T257","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G67124MW\""},{"id":"GlycanIUPAC_T258","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G71457ZU\""},{"id":"GlycanIUPAC_T259","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G55228VZ\""},{"id":"GlycanIUPAC_T260","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G31034MJ\""},{"id":"GlycanIUPAC_T261","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G25776IP\""},{"id":"GlycanIUPAC_T262","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G64442BV\""},{"id":"GlycanIUPAC_T263","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G57018LE\""},{"id":"GlycanIUPAC_T264","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G61761GX\""},{"id":"GlycanIUPAC_T265","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G76318UX\""},{"id":"GlycanIUPAC_T266","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G61906ER\""},{"id":"GlycanIUPAC_T267","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G68723GR\""},{"id":"GlycanIUPAC_T268","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G19540LE\""},{"id":"GlycanIUPAC_T269","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G74944PO\""},{"id":"GlycanIUPAC_T270","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G89489ZJ\""},{"id":"GlycanIUPAC_T271","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G04434YU\""},{"id":"GlycanIUPAC_T272","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G21450PB\""},{"id":"GlycanIUPAC_T273","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G93629QY\""},{"id":"GlycanIUPAC_T274","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G02603TR\""},{"id":"GlycanIUPAC_T275","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G40280JP\""},{"id":"GlycanIUPAC_T276","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G95259IC\""},{"id":"GlycanIUPAC_T277","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G26900FE\""},{"id":"GlycanIUPAC_T278","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G21346KK\""},{"id":"GlycanIUPAC_T279","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G62509FF\""},{"id":"GlycanIUPAC_T280","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G83932AK\""},{"id":"GlycanIUPAC_T281","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G96978IB\""},{"id":"GlycanIUPAC_T282","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G34275DN\""},{"id":"GlycanIUPAC_T283","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G07071JF\""},{"id":"GlycanIUPAC_T284","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G80639QD\""},{"id":"GlycanIUPAC_T285","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G99460PJ\""},{"id":"GlycanIUPAC_T286","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G22024BZ\""},{"id":"GlycanIUPAC_T287","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G74097ZY\""},{"id":"GlycanIUPAC_T288","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G84439YP\""},{"id":"GlycanIUPAC_T289","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G52207WQ\""},{"id":"GlycanIUPAC_T290","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G90695MS\""},{"id":"GlycanIUPAC_T291","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G50398QX\""},{"id":"GlycanIUPAC_T292","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G12166ZT\""},{"id":"GlycanIUPAC_T293","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G48368BR\""},{"id":"GlycanIUPAC_T294","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G57407RW\""},{"id":"GlycanIUPAC_T295","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G00386TY\""},{"id":"GlycanIUPAC_T296","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G18723JK\""},{"id":"GlycanIUPAC_T297","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G93757OR\""},{"id":"GlycanIUPAC_T298","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G29006SI\""},{"id":"GlycanIUPAC_T299","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G03099OQ\""},{"id":"GlycanIUPAC_T300","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G53739OW\""},{"id":"GlycanIUPAC_T301","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G70440ZO\""},{"id":"GlycanIUPAC_T302","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G29951RR\""},{"id":"GlycanIUPAC_T303","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G58402TI\""},{"id":"GlycanIUPAC_T304","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G39875TP\""},{"id":"GlycanIUPAC_T305","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G83439QV\""},{"id":"GlycanIUPAC_T306","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G41762RC\""},{"id":"GlycanIUPAC_T307","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G91604UI\""},{"id":"GlycanIUPAC_T308","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G88447WE\""},{"id":"GlycanIUPAC_T309","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G93634BS\""},{"id":"GlycanIUPAC_T310","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G02587BH\""},{"id":"GlycanIUPAC_T311","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G43511MX\""},{"id":"GlycanIUPAC_T312","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G64958DH\""},{"id":"GlycanIUPAC_T313","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G30384TR\""},{"id":"GlycanIUPAC_T314","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G15624EX\""},{"id":"GlycanIUPAC_T315","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G22706ST\""},{"id":"GlycanIUPAC_T316","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G57408PI\""},{"id":"GlycanIUPAC_T317","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G86403XX\""},{"id":"GlycanIUPAC_T318","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G78043YB\""},{"id":"GlycanIUPAC_T319","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G18952JK\""},{"id":"GlycanIUPAC_T320","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G49020ND\""},{"id":"GlycanIUPAC_T321","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G63590YW\""},{"id":"GlycanIUPAC_T322","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G22793KS\""},{"id":"GlycanIUPAC_T323","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G64134SS\""},{"id":"GlycanIUPAC_T324","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G17338HY\""},{"id":"GlycanIUPAC_T325","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G99745XF\""},{"id":"GlycanIUPAC_T326","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G27782HN\""},{"id":"GlycanIUPAC_T327","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G57496DC\""},{"id":"GlycanIUPAC_T328","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G93169WB\""},{"id":"GlycanIUPAC_T329","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G05518TD\""},{"id":"GlycanIUPAC_T330","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G62603DN\""},{"id":"GlycanIUPAC_T331","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G59574FS\""},{"id":"GlycanIUPAC_T332","span":{"begin":568,"end":571},"obj":"\"http://rdf.glycoinfo.org/glycan/G47567WC\""},{"id":"GlycanIUPAC_T333","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G93924TT\""},{"id":"GlycanIUPAC_T334","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G93924TT\""},{"id":"GlycanIUPAC_T335","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G93924TT\""},{"id":"GlycanIUPAC_T336","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G25565DN\""},{"id":"GlycanIUPAC_T337","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G25565DN\""},{"id":"GlycanIUPAC_T338","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G25565DN\""},{"id":"GlycanIUPAC_T339","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G97215EV\""},{"id":"GlycanIUPAC_T340","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G97215EV\""},{"id":"GlycanIUPAC_T341","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G97215EV\""},{"id":"GlycanIUPAC_T342","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G79664KO\""},{"id":"GlycanIUPAC_T343","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G79664KO\""},{"id":"GlycanIUPAC_T344","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G79664KO\""},{"id":"GlycanIUPAC_T345","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G24107FU\""},{"id":"GlycanIUPAC_T346","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G24107FU\""},{"id":"GlycanIUPAC_T347","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G24107FU\""},{"id":"GlycanIUPAC_T348","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G09864UE\""},{"id":"GlycanIUPAC_T349","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G09864UE\""},{"id":"GlycanIUPAC_T350","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G09864UE\""},{"id":"GlycanIUPAC_T351","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G28032MC\""},{"id":"GlycanIUPAC_T352","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G28032MC\""},{"id":"GlycanIUPAC_T353","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G28032MC\""},{"id":"GlycanIUPAC_T354","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G28005UP\""},{"id":"GlycanIUPAC_T355","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G28005UP\""},{"id":"GlycanIUPAC_T356","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G28005UP\""},{"id":"GlycanIUPAC_T357","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G92708AT\""},{"id":"GlycanIUPAC_T358","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G92708AT\""},{"id":"GlycanIUPAC_T359","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G92708AT\""},{"id":"GlycanIUPAC_T360","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G73757UC\""},{"id":"GlycanIUPAC_T361","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G73757UC\""},{"id":"GlycanIUPAC_T362","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G73757UC\""},{"id":"GlycanIUPAC_T363","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G51062DM\""},{"id":"GlycanIUPAC_T364","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G51062DM\""},{"id":"GlycanIUPAC_T365","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G51062DM\""},{"id":"GlycanIUPAC_T366","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G05866BJ\""},{"id":"GlycanIUPAC_T367","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G05866BJ\""},{"id":"GlycanIUPAC_T368","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G05866BJ\""},{"id":"GlycanIUPAC_T369","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G87394FZ\""},{"id":"GlycanIUPAC_T370","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G87394FZ\""},{"id":"GlycanIUPAC_T371","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G87394FZ\""},{"id":"GlycanIUPAC_T372","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G03871NF\""},{"id":"GlycanIUPAC_T373","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G03871NF\""},{"id":"GlycanIUPAC_T374","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G03871NF\""},{"id":"GlycanIUPAC_T375","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G29377VE\""},{"id":"GlycanIUPAC_T376","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G29377VE\""},{"id":"GlycanIUPAC_T377","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G29377VE\""},{"id":"GlycanIUPAC_T378","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G33457CX\""},{"id":"GlycanIUPAC_T379","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G33457CX\""},{"id":"GlycanIUPAC_T380","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G33457CX\""},{"id":"GlycanIUPAC_T381","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G97368GU\""},{"id":"GlycanIUPAC_T382","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G97368GU\""},{"id":"GlycanIUPAC_T383","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G97368GU\""},{"id":"GlycanIUPAC_T384","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G18512EL\""},{"id":"GlycanIUPAC_T385","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G18512EL\""},{"id":"GlycanIUPAC_T386","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G18512EL\""},{"id":"GlycanIUPAC_T387","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G41137VS\""},{"id":"GlycanIUPAC_T388","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G41137VS\""},{"id":"GlycanIUPAC_T389","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G41137VS\""},{"id":"GlycanIUPAC_T390","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G30521NA\""},{"id":"GlycanIUPAC_T391","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G30521NA\""},{"id":"GlycanIUPAC_T392","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G30521NA\""},{"id":"GlycanIUPAC_T393","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G19388CD\""},{"id":"GlycanIUPAC_T394","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G19388CD\""},{"id":"GlycanIUPAC_T395","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G19388CD\""},{"id":"GlycanIUPAC_T396","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G53151FU\""},{"id":"GlycanIUPAC_T397","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G53151FU\""},{"id":"GlycanIUPAC_T398","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G53151FU\""},{"id":"GlycanIUPAC_T399","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G27105XC\""},{"id":"GlycanIUPAC_T400","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G27105XC\""},{"id":"GlycanIUPAC_T401","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G27105XC\""},{"id":"GlycanIUPAC_T402","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G91210VM\""},{"id":"GlycanIUPAC_T403","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G91210VM\""},{"id":"GlycanIUPAC_T404","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G91210VM\""},{"id":"GlycanIUPAC_T405","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G40841DE\""},{"id":"GlycanIUPAC_T406","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G40841DE\""},{"id":"GlycanIUPAC_T407","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G40841DE\""},{"id":"GlycanIUPAC_T408","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G71241HP\""},{"id":"GlycanIUPAC_T409","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G71241HP\""},{"id":"GlycanIUPAC_T410","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G71241HP\""},{"id":"GlycanIUPAC_T411","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G84636BJ\""},{"id":"GlycanIUPAC_T412","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G84636BJ\""},{"id":"GlycanIUPAC_T413","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G84636BJ\""},{"id":"GlycanIUPAC_T414","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G47905LJ\""},{"id":"GlycanIUPAC_T415","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G47905LJ\""},{"id":"GlycanIUPAC_T416","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G47905LJ\""},{"id":"GlycanIUPAC_T417","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G39340DV\""},{"id":"GlycanIUPAC_T418","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G39340DV\""},{"id":"GlycanIUPAC_T419","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G39340DV\""},{"id":"GlycanIUPAC_T420","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G48801AQ\""},{"id":"GlycanIUPAC_T421","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G48801AQ\""},{"id":"GlycanIUPAC_T422","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G48801AQ\""},{"id":"GlycanIUPAC_T423","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G14573NX\""},{"id":"GlycanIUPAC_T424","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G14573NX\""},{"id":"GlycanIUPAC_T425","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G14573NX\""},{"id":"GlycanIUPAC_T426","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G56762TR\""},{"id":"GlycanIUPAC_T427","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G56762TR\""},{"id":"GlycanIUPAC_T428","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G56762TR\""},{"id":"GlycanIUPAC_T429","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G20013XO\""},{"id":"GlycanIUPAC_T430","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G20013XO\""},{"id":"GlycanIUPAC_T431","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G20013XO\""},{"id":"GlycanIUPAC_T432","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G39504DR\""},{"id":"GlycanIUPAC_T433","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G39504DR\""},{"id":"GlycanIUPAC_T434","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G39504DR\""},{"id":"GlycanIUPAC_T435","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G35218RQ\""},{"id":"GlycanIUPAC_T436","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G35218RQ\""},{"id":"GlycanIUPAC_T437","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G35218RQ\""},{"id":"GlycanIUPAC_T438","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G53048SH\""},{"id":"GlycanIUPAC_T439","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G53048SH\""},{"id":"GlycanIUPAC_T440","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G53048SH\""},{"id":"GlycanIUPAC_T441","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G78418IX\""},{"id":"GlycanIUPAC_T442","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G78418IX\""},{"id":"GlycanIUPAC_T443","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G78418IX\""},{"id":"GlycanIUPAC_T444","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G09780OD\""},{"id":"GlycanIUPAC_T445","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G09780OD\""},{"id":"GlycanIUPAC_T446","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G09780OD\""},{"id":"GlycanIUPAC_T447","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G56359GL\""},{"id":"GlycanIUPAC_T448","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G56359GL\""},{"id":"GlycanIUPAC_T449","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G56359GL\""},{"id":"GlycanIUPAC_T450","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G78941YC\""},{"id":"GlycanIUPAC_T451","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G78941YC\""},{"id":"GlycanIUPAC_T452","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G78941YC\""},{"id":"GlycanIUPAC_T453","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G26829FC\""},{"id":"GlycanIUPAC_T454","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G26829FC\""},{"id":"GlycanIUPAC_T455","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G26829FC\""},{"id":"GlycanIUPAC_T456","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G88538ZC\""},{"id":"GlycanIUPAC_T457","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G88538ZC\""},{"id":"GlycanIUPAC_T458","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G88538ZC\""},{"id":"GlycanIUPAC_T459","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G46593ZR\""},{"id":"GlycanIUPAC_T460","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G46593ZR\""},{"id":"GlycanIUPAC_T461","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G46593ZR\""},{"id":"GlycanIUPAC_T462","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G43523TH\""},{"id":"GlycanIUPAC_T463","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G43523TH\""},{"id":"GlycanIUPAC_T464","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G43523TH\""},{"id":"GlycanIUPAC_T465","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G36445ON\""},{"id":"GlycanIUPAC_T466","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G36445ON\""},{"id":"GlycanIUPAC_T467","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G36445ON\""},{"id":"GlycanIUPAC_T468","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G67363FK\""},{"id":"GlycanIUPAC_T469","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G67363FK\""},{"id":"GlycanIUPAC_T470","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G67363FK\""},{"id":"GlycanIUPAC_T471","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G17562KT\""},{"id":"GlycanIUPAC_T472","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G17562KT\""},{"id":"GlycanIUPAC_T473","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G17562KT\""},{"id":"GlycanIUPAC_T474","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G24774YJ\""},{"id":"GlycanIUPAC_T475","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G24774YJ\""},{"id":"GlycanIUPAC_T476","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G24774YJ\""},{"id":"GlycanIUPAC_T477","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G32162UO\""},{"id":"GlycanIUPAC_T478","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G32162UO\""},{"id":"GlycanIUPAC_T479","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G32162UO\""},{"id":"GlycanIUPAC_T480","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G89163RR\""},{"id":"GlycanIUPAC_T481","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G89163RR\""},{"id":"GlycanIUPAC_T482","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G89163RR\""},{"id":"GlycanIUPAC_T483","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G99522DY\""},{"id":"GlycanIUPAC_T484","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G99522DY\""},{"id":"GlycanIUPAC_T485","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G99522DY\""},{"id":"GlycanIUPAC_T486","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G59246IF\""},{"id":"GlycanIUPAC_T487","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G59246IF\""},{"id":"GlycanIUPAC_T488","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G59246IF\""},{"id":"GlycanIUPAC_T489","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G95321NT\""},{"id":"GlycanIUPAC_T490","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G95321NT\""},{"id":"GlycanIUPAC_T491","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G95321NT\""},{"id":"GlycanIUPAC_T492","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G17531ZI\""},{"id":"GlycanIUPAC_T493","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G17531ZI\""},{"id":"GlycanIUPAC_T494","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G17531ZI\""},{"id":"GlycanIUPAC_T495","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G54322SU\""},{"id":"GlycanIUPAC_T496","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G54322SU\""},{"id":"GlycanIUPAC_T497","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G54322SU\""},{"id":"GlycanIUPAC_T498","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G72010DO\""},{"id":"GlycanIUPAC_T499","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G72010DO\""},{"id":"GlycanIUPAC_T500","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G72010DO\""},{"id":"GlycanIUPAC_T501","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G44269EP\""},{"id":"GlycanIUPAC_T502","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G44269EP\""},{"id":"GlycanIUPAC_T503","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G44269EP\""},{"id":"GlycanIUPAC_T504","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G57335AD\""},{"id":"GlycanIUPAC_T505","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G57335AD\""},{"id":"GlycanIUPAC_T506","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G57335AD\""},{"id":"GlycanIUPAC_T507","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G60837LL\""},{"id":"GlycanIUPAC_T508","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G60837LL\""},{"id":"GlycanIUPAC_T509","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G60837LL\""},{"id":"GlycanIUPAC_T510","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G61929XX\""},{"id":"GlycanIUPAC_T511","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G61929XX\""},{"id":"GlycanIUPAC_T512","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G61929XX\""},{"id":"GlycanIUPAC_T513","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G88747RA\""},{"id":"GlycanIUPAC_T514","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G88747RA\""},{"id":"GlycanIUPAC_T515","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G88747RA\""},{"id":"GlycanIUPAC_T516","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G47955HA\""},{"id":"GlycanIUPAC_T517","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G47955HA\""},{"id":"GlycanIUPAC_T518","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G47955HA\""},{"id":"GlycanIUPAC_T519","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G60982WS\""},{"id":"GlycanIUPAC_T520","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G60982WS\""},{"id":"GlycanIUPAC_T521","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G60982WS\""},{"id":"GlycanIUPAC_T522","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G37035KG\""},{"id":"GlycanIUPAC_T523","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G37035KG\""},{"id":"GlycanIUPAC_T524","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G37035KG\""},{"id":"GlycanIUPAC_T525","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G46297FI\""},{"id":"GlycanIUPAC_T526","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G46297FI\""},{"id":"GlycanIUPAC_T527","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G46297FI\""},{"id":"GlycanIUPAC_T528","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G35475KI\""},{"id":"GlycanIUPAC_T529","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G35475KI\""},{"id":"GlycanIUPAC_T530","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G35475KI\""},{"id":"GlycanIUPAC_T531","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G29771JN\""},{"id":"GlycanIUPAC_T532","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G29771JN\""},{"id":"GlycanIUPAC_T533","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G29771JN\""},{"id":"GlycanIUPAC_T534","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G61285YR\""},{"id":"GlycanIUPAC_T535","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G61285YR\""},{"id":"GlycanIUPAC_T536","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G61285YR\""},{"id":"GlycanIUPAC_T537","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G54785MW\""},{"id":"GlycanIUPAC_T538","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G54785MW\""},{"id":"GlycanIUPAC_T539","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G54785MW\""},{"id":"GlycanIUPAC_T540","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G53039GT\""},{"id":"GlycanIUPAC_T541","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G53039GT\""},{"id":"GlycanIUPAC_T542","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G53039GT\""},{"id":"GlycanIUPAC_T543","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G00601HK\""},{"id":"GlycanIUPAC_T544","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G00601HK\""},{"id":"GlycanIUPAC_T545","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G00601HK\""},{"id":"GlycanIUPAC_T546","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G10485IJ\""},{"id":"GlycanIUPAC_T547","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G10485IJ\""},{"id":"GlycanIUPAC_T548","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G10485IJ\""},{"id":"GlycanIUPAC_T549","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G16393IB\""},{"id":"GlycanIUPAC_T550","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G16393IB\""},{"id":"GlycanIUPAC_T551","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G16393IB\""},{"id":"GlycanIUPAC_T552","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G98436FZ\""},{"id":"GlycanIUPAC_T553","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G98436FZ\""},{"id":"GlycanIUPAC_T554","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G98436FZ\""},{"id":"GlycanIUPAC_T555","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G18825IA\""},{"id":"GlycanIUPAC_T556","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G18825IA\""},{"id":"GlycanIUPAC_T557","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G18825IA\""},{"id":"GlycanIUPAC_T558","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G61281HQ\""},{"id":"GlycanIUPAC_T559","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G61281HQ\""},{"id":"GlycanIUPAC_T560","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G61281HQ\""},{"id":"GlycanIUPAC_T561","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G07798TI\""},{"id":"GlycanIUPAC_T562","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G07798TI\""},{"id":"GlycanIUPAC_T563","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G07798TI\""},{"id":"GlycanIUPAC_T564","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G55921QA\""},{"id":"GlycanIUPAC_T565","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G55921QA\""},{"id":"GlycanIUPAC_T566","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G55921QA\""},{"id":"GlycanIUPAC_T567","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G99066DL\""},{"id":"GlycanIUPAC_T568","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G99066DL\""},{"id":"GlycanIUPAC_T569","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G99066DL\""},{"id":"GlycanIUPAC_T570","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G33451PQ\""},{"id":"GlycanIUPAC_T571","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G33451PQ\""},{"id":"GlycanIUPAC_T572","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G33451PQ\""},{"id":"GlycanIUPAC_T573","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G02111XU\""},{"id":"GlycanIUPAC_T574","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G02111XU\""},{"id":"GlycanIUPAC_T575","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G02111XU\""},{"id":"GlycanIUPAC_T576","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G85193OM\""},{"id":"GlycanIUPAC_T577","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G85193OM\""},{"id":"GlycanIUPAC_T578","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G85193OM\""},{"id":"GlycanIUPAC_T579","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G89174YQ\""},{"id":"GlycanIUPAC_T580","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G89174YQ\""},{"id":"GlycanIUPAC_T581","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G89174YQ\""},{"id":"GlycanIUPAC_T582","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G28802LE\""},{"id":"GlycanIUPAC_T583","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G28802LE\""},{"id":"GlycanIUPAC_T584","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G28802LE\""},{"id":"GlycanIUPAC_T585","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G56061JK\""},{"id":"GlycanIUPAC_T586","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G56061JK\""},{"id":"GlycanIUPAC_T587","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G56061JK\""},{"id":"GlycanIUPAC_T588","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G68941BC\""},{"id":"GlycanIUPAC_T589","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G68941BC\""},{"id":"GlycanIUPAC_T590","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G68941BC\""},{"id":"GlycanIUPAC_T591","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G55436FC\""},{"id":"GlycanIUPAC_T592","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G55436FC\""},{"id":"GlycanIUPAC_T593","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G55436FC\""},{"id":"GlycanIUPAC_T594","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G24002PU\""},{"id":"GlycanIUPAC_T595","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G24002PU\""},{"id":"GlycanIUPAC_T596","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G24002PU\""},{"id":"GlycanIUPAC_T597","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G61387SV\""},{"id":"GlycanIUPAC_T598","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G61387SV\""},{"id":"GlycanIUPAC_T599","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G61387SV\""},{"id":"GlycanIUPAC_T600","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G31834HW\""},{"id":"GlycanIUPAC_T601","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G31834HW\""},{"id":"GlycanIUPAC_T602","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G31834HW\""},{"id":"GlycanIUPAC_T603","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G35324RT\""},{"id":"GlycanIUPAC_T604","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G35324RT\""},{"id":"GlycanIUPAC_T605","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G35324RT\""},{"id":"GlycanIUPAC_T606","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G34803QO\""},{"id":"GlycanIUPAC_T607","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G34803QO\""},{"id":"GlycanIUPAC_T608","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G34803QO\""},{"id":"GlycanIUPAC_T609","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G92898FF\""},{"id":"GlycanIUPAC_T610","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G92898FF\""},{"id":"GlycanIUPAC_T611","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G92898FF\""},{"id":"GlycanIUPAC_T612","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G01318VX\""},{"id":"GlycanIUPAC_T613","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G01318VX\""},{"id":"GlycanIUPAC_T614","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G01318VX\""},{"id":"GlycanIUPAC_T615","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G83200MX\""},{"id":"GlycanIUPAC_T616","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G83200MX\""},{"id":"GlycanIUPAC_T617","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G83200MX\""},{"id":"GlycanIUPAC_T618","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G56286UC\""},{"id":"GlycanIUPAC_T619","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G56286UC\""},{"id":"GlycanIUPAC_T620","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G56286UC\""},{"id":"GlycanIUPAC_T621","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G07304QA\""},{"id":"GlycanIUPAC_T622","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G07304QA\""},{"id":"GlycanIUPAC_T623","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G07304QA\""},{"id":"GlycanIUPAC_T624","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G06868OU\""},{"id":"GlycanIUPAC_T625","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G06868OU\""},{"id":"GlycanIUPAC_T626","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G06868OU\""},{"id":"GlycanIUPAC_T627","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G12647BS\""},{"id":"GlycanIUPAC_T628","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G12647BS\""},{"id":"GlycanIUPAC_T629","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G12647BS\""},{"id":"GlycanIUPAC_T630","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G51841DF\""},{"id":"GlycanIUPAC_T631","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G51841DF\""},{"id":"GlycanIUPAC_T632","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G51841DF\""},{"id":"GlycanIUPAC_T633","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G32122AJ\""},{"id":"GlycanIUPAC_T634","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G32122AJ\""},{"id":"GlycanIUPAC_T635","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G32122AJ\""},{"id":"GlycanIUPAC_T636","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G41125MN\""},{"id":"GlycanIUPAC_T637","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G41125MN\""},{"id":"GlycanIUPAC_T638","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G41125MN\""},{"id":"GlycanIUPAC_T639","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G16093XS\""},{"id":"GlycanIUPAC_T640","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G16093XS\""},{"id":"GlycanIUPAC_T641","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G16093XS\""},{"id":"GlycanIUPAC_T642","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G62425IX\""},{"id":"GlycanIUPAC_T643","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G62425IX\""},{"id":"GlycanIUPAC_T644","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G62425IX\""},{"id":"GlycanIUPAC_T645","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G15673TO\""},{"id":"GlycanIUPAC_T646","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G15673TO\""},{"id":"GlycanIUPAC_T647","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G15673TO\""},{"id":"GlycanIUPAC_T648","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G32857IK\""},{"id":"GlycanIUPAC_T649","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G32857IK\""},{"id":"GlycanIUPAC_T650","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G32857IK\""},{"id":"GlycanIUPAC_T651","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G60047CJ\""},{"id":"GlycanIUPAC_T652","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G60047CJ\""},{"id":"GlycanIUPAC_T653","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G60047CJ\""},{"id":"GlycanIUPAC_T654","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G55718ZB\""},{"id":"GlycanIUPAC_T655","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G55718ZB\""},{"id":"GlycanIUPAC_T656","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G55718ZB\""},{"id":"GlycanIUPAC_T657","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G88355ZE\""},{"id":"GlycanIUPAC_T658","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G88355ZE\""},{"id":"GlycanIUPAC_T659","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G88355ZE\""},{"id":"GlycanIUPAC_T660","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G11283PA\""},{"id":"GlycanIUPAC_T661","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G11283PA\""},{"id":"GlycanIUPAC_T662","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G11283PA\""},{"id":"GlycanIUPAC_T663","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G71737IZ\""},{"id":"GlycanIUPAC_T664","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G71737IZ\""},{"id":"GlycanIUPAC_T665","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G71737IZ\""},{"id":"GlycanIUPAC_T666","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G60912WZ\""},{"id":"GlycanIUPAC_T667","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G60912WZ\""},{"id":"GlycanIUPAC_T668","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G60912WZ\""},{"id":"GlycanIUPAC_T669","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G99655SO\""},{"id":"GlycanIUPAC_T670","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G99655SO\""},{"id":"GlycanIUPAC_T671","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G99655SO\""},{"id":"GlycanIUPAC_T672","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G10300TW\""},{"id":"GlycanIUPAC_T673","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G10300TW\""},{"id":"GlycanIUPAC_T674","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G10300TW\""},{"id":"GlycanIUPAC_T675","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G89509FL\""},{"id":"GlycanIUPAC_T676","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G89509FL\""},{"id":"GlycanIUPAC_T677","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G89509FL\""},{"id":"GlycanIUPAC_T678","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G31465TH\""},{"id":"GlycanIUPAC_T679","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G31465TH\""},{"id":"GlycanIUPAC_T680","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G31465TH\""},{"id":"GlycanIUPAC_T681","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G94101LU\""},{"id":"GlycanIUPAC_T682","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G94101LU\""},{"id":"GlycanIUPAC_T683","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G94101LU\""},{"id":"GlycanIUPAC_T684","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G38610BB\""},{"id":"GlycanIUPAC_T685","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G38610BB\""},{"id":"GlycanIUPAC_T686","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G38610BB\""},{"id":"GlycanIUPAC_T687","span":{"begin":988,"end":991},"obj":"\"http://rdf.glycoinfo.org/glycan/G85893UF\""},{"id":"GlycanIUPAC_T688","span":{"begin":1110,"end":1113},"obj":"\"http://rdf.glycoinfo.org/glycan/G85893UF\""},{"id":"GlycanIUPAC_T689","span":{"begin":1211,"end":1214},"obj":"\"http://rdf.glycoinfo.org/glycan/G85893UF\""},{"id":"GlycanIUPAC_T690","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T691","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T692","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T693","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T694","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T695","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T696","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G76685HR\""},{"id":"GlycanIUPAC_T697","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T698","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T699","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T700","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T701","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T702","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T703","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G65881BF\""},{"id":"GlycanIUPAC_T704","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T705","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T706","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T707","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T708","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T709","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T710","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G82702MH\""},{"id":"GlycanIUPAC_T711","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T712","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T713","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T714","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T715","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T716","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T717","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G51494MY\""},{"id":"GlycanIUPAC_T718","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T719","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T720","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T721","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T722","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T723","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T724","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G37109XL\""},{"id":"GlycanIUPAC_T725","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T726","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T727","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T728","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T729","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T730","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T731","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G47427MX\""},{"id":"GlycanIUPAC_T732","span":{"begin":1031,"end":1037},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T733","span":{"begin":1091,"end":1097},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T734","span":{"begin":1145,"end":1151},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T735","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T736","span":{"begin":1423,"end":1429},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T737","span":{"begin":1510,"end":1516},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T738","span":{"begin":1603,"end":1609},"obj":"\"http://rdf.glycoinfo.org/glycan/G89927NS\""},{"id":"GlycanIUPAC_T739","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G23425WZ\""},{"id":"GlycanIUPAC_T740","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G23425WZ\""},{"id":"GlycanIUPAC_T741","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G02874VH\""},{"id":"GlycanIUPAC_T742","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G02874VH\""},{"id":"GlycanIUPAC_T743","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G99699DW\""},{"id":"GlycanIUPAC_T744","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G99699DW\""},{"id":"GlycanIUPAC_T745","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G22074RM\""},{"id":"GlycanIUPAC_T746","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G22074RM\""},{"id":"GlycanIUPAC_T747","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G48535VZ\""},{"id":"GlycanIUPAC_T748","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G48535VZ\""},{"id":"GlycanIUPAC_T749","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G39738WL\""},{"id":"GlycanIUPAC_T750","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G39738WL\""},{"id":"GlycanIUPAC_T751","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G42313WU\""},{"id":"GlycanIUPAC_T752","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G42313WU\""},{"id":"GlycanIUPAC_T753","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G00393CK\""},{"id":"GlycanIUPAC_T754","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G00393CK\""},{"id":"GlycanIUPAC_T755","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G42649EX\""},{"id":"GlycanIUPAC_T756","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G42649EX\""},{"id":"GlycanIUPAC_T757","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G46880SB\""},{"id":"GlycanIUPAC_T758","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G46880SB\""},{"id":"GlycanIUPAC_T759","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G75599IR\""},{"id":"GlycanIUPAC_T760","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G75599IR\""},{"id":"GlycanIUPAC_T761","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G58985MU\""},{"id":"GlycanIUPAC_T762","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G58985MU\""},{"id":"GlycanIUPAC_T763","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G92517PO\""},{"id":"GlycanIUPAC_T764","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G92517PO\""},{"id":"GlycanIUPAC_T765","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G88512YL\""},{"id":"GlycanIUPAC_T766","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G88512YL\""},{"id":"GlycanIUPAC_T767","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G41473NX\""},{"id":"GlycanIUPAC_T768","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G41473NX\""},{"id":"GlycanIUPAC_T769","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G71089RB\""},{"id":"GlycanIUPAC_T770","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G71089RB\""},{"id":"GlycanIUPAC_T771","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G73485GZ\""},{"id":"GlycanIUPAC_T772","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G73485GZ\""},{"id":"GlycanIUPAC_T773","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G61406KC\""},{"id":"GlycanIUPAC_T774","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G61406KC\""},{"id":"GlycanIUPAC_T775","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G34412GZ\""},{"id":"GlycanIUPAC_T776","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G34412GZ\""},{"id":"GlycanIUPAC_T777","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G67209FP\""},{"id":"GlycanIUPAC_T778","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G67209FP\""},{"id":"GlycanIUPAC_T779","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G61442IL\""},{"id":"GlycanIUPAC_T780","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G61442IL\""},{"id":"GlycanIUPAC_T781","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G93729MV\""},{"id":"GlycanIUPAC_T782","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G93729MV\""},{"id":"GlycanIUPAC_T783","span":{"begin":1312,"end":1318},"obj":"\"http://rdf.glycoinfo.org/glycan/G92144AE\""},{"id":"GlycanIUPAC_T784","span":{"begin":1442,"end":1448},"obj":"\"http://rdf.glycoinfo.org/glycan/G92144AE\""}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":1958,"end":2017},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"T7","span":{"begin":1958,"end":2017},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"T7","span":{"begin":1958,"end":2017},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
Lectin
{"project":"Lectin","denotations":[{"id":"Lectin_T1","span":{"begin":1766,"end":1769},"obj":"https://acgg.asia/db/lfdb/LfDB0050"},{"id":"Lectin_T2","span":{"begin":1940,"end":1943},"obj":"https://acgg.asia/db/lfdb/LfDB0050"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlycoBiology-Epitope
{"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T1","span":{"begin":919,"end":923},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"PD-GlycoEpitope-B_T2","span":{"begin":1038,"end":1042},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"PD-GlycoEpitope-B_T3","span":{"begin":1496,"end":1500},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"PD-GlycoEpitope-B_T4","span":{"begin":1517,"end":1521},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":52,"end":58},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":265,"end":271},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"PD-UBERON-AE-B_T3","span":{"begin":550,"end":556},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"PD-UBERON-AE-B_T4","span":{"begin":753,"end":759},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
Anatomy-MAT
{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"Body_part"},{"id":"T2","span":{"begin":265,"end":271},"obj":"Body_part"},{"id":"T3","span":{"begin":445,"end":450},"obj":"Body_part"},{"id":"T5","span":{"begin":550,"end":556},"obj":"Body_part"},{"id":"T6","span":{"begin":704,"end":709},"obj":"Body_part"},{"id":"T8","span":{"begin":753,"end":759},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"A2","pred":"mat_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"A4","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"A5","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"A6","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"A7","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"A8","pred":"mat_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MAT_0000132"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
Glycan-GlyCosmos
{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":457,"end":460},"obj":"Glycan"},{"id":"T2","span":{"begin":919,"end":923},"obj":"Glycan"},{"id":"T3","span":{"begin":1031,"end":1037},"obj":"Glycan"},{"id":"T4","span":{"begin":1038,"end":1042},"obj":"Glycan"},{"id":"T5","span":{"begin":1091,"end":1097},"obj":"Glycan"},{"id":"T6","span":{"begin":1145,"end":1151},"obj":"Glycan"},{"id":"T7","span":{"begin":1255,"end":1264},"obj":"Glycan"},{"id":"T8","span":{"begin":1312,"end":1318},"obj":"Glycan"},{"id":"T9","span":{"begin":1375,"end":1381},"obj":"Glycan"},{"id":"T10","span":{"begin":1382,"end":1391},"obj":"Glycan"},{"id":"T11","span":{"begin":1423,"end":1429},"obj":"Glycan"},{"id":"T12","span":{"begin":1442,"end":1448},"obj":"Glycan"},{"id":"T13","span":{"begin":1496,"end":1500},"obj":"Glycan"},{"id":"T14","span":{"begin":1510,"end":1516},"obj":"Glycan"},{"id":"T15","span":{"begin":1517,"end":1521},"obj":"Glycan"},{"id":"T16","span":{"begin":1584,"end":1593},"obj":"Glycan"},{"id":"T17","span":{"begin":1603,"end":1609},"obj":"Glycan"},{"id":"T18","span":{"begin":1610,"end":1619},"obj":"Glycan"},{"id":"T19","span":{"begin":1687,"end":1690},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A20","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A21","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A22","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A23","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A24","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A6","pred":"glycosmos_id","subj":"T6","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A25","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A26","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A8","pred":"glycosmos_id","subj":"T8","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A27","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A9","pred":"glycosmos_id","subj":"T9","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A28","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A10","pred":"glycosmos_id","subj":"T10","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A29","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A30","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A31","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A13","pred":"glycosmos_id","subj":"T13","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A32","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A14","pred":"glycosmos_id","subj":"T14","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A33","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A15","pred":"glycosmos_id","subj":"T15","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A34","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A16","pred":"glycosmos_id","subj":"T16","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A35","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A17","pred":"glycosmos_id","subj":"T17","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A36","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A18","pred":"glycosmos_id","subj":"T18","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A37","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A19","pred":"glycosmos_id","subj":"T19","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A38","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos-GlycoEpitope
{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":919,"end":923},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":1038,"end":1042},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":1496,"end":1500},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T4","span":{"begin":1517,"end":1521},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A4","pred":"glycoepitope_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-CL
{"project":"GlyCosmos15-CL","denotations":[{"id":"T1","span":{"begin":445,"end":450},"obj":"Cell"},{"id":"T2","span":{"begin":704,"end":709},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000019"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000019"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-UBERON
{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"Body_part"},{"id":"T2","span":{"begin":265,"end":271},"obj":"Body_part"},{"id":"T3","span":{"begin":445,"end":450},"obj":"Body_part"},{"id":"T5","span":{"begin":550,"end":556},"obj":"Body_part"},{"id":"T6","span":{"begin":704,"end":709},"obj":"Body_part"},{"id":"T8","span":{"begin":753,"end":759},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000019"},{"id":"A4","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0001968"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CL_0000019"},{"id":"A7","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0001968"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-MAT
{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"Body_part"},{"id":"T2","span":{"begin":265,"end":271},"obj":"Body_part"},{"id":"T3","span":{"begin":445,"end":450},"obj":"Body_part"},{"id":"T5","span":{"begin":550,"end":556},"obj":"Body_part"},{"id":"T6","span":{"begin":704,"end":709},"obj":"Body_part"},{"id":"T8","span":{"begin":753,"end":759},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"A2","pred":"mat_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"A4","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"A5","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000132"},{"id":"A6","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000131"},{"id":"A7","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000218"},{"id":"A8","pred":"mat_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MAT_0000132"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":1958,"end":2017},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"T7","span":{"begin":1958,"end":2017},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"T7","span":{"begin":1958,"end":2017},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T2","span":{"begin":119,"end":404},"obj":"Sentence"},{"id":"T3","span":{"begin":405,"end":597},"obj":"Sentence"},{"id":"T4","span":{"begin":598,"end":797},"obj":"Sentence"},{"id":"T5","span":{"begin":798,"end":1675},"obj":"Sentence"},{"id":"T6","span":{"begin":1676,"end":1957},"obj":"Sentence"},{"id":"T7","span":{"begin":1958,"end":2017},"obj":"Sentence"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-Glycan
{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":457,"end":460},"obj":"Glycan"},{"id":"T2","span":{"begin":919,"end":923},"obj":"Glycan"},{"id":"T3","span":{"begin":1031,"end":1037},"obj":"Glycan"},{"id":"T4","span":{"begin":1038,"end":1042},"obj":"Glycan"},{"id":"T5","span":{"begin":1091,"end":1097},"obj":"Glycan"},{"id":"T6","span":{"begin":1145,"end":1151},"obj":"Glycan"},{"id":"T7","span":{"begin":1255,"end":1264},"obj":"Glycan"},{"id":"T8","span":{"begin":1312,"end":1318},"obj":"Glycan"},{"id":"T9","span":{"begin":1375,"end":1381},"obj":"Glycan"},{"id":"T10","span":{"begin":1382,"end":1391},"obj":"Glycan"},{"id":"T11","span":{"begin":1423,"end":1429},"obj":"Glycan"},{"id":"T12","span":{"begin":1442,"end":1448},"obj":"Glycan"},{"id":"T13","span":{"begin":1496,"end":1500},"obj":"Glycan"},{"id":"T14","span":{"begin":1510,"end":1516},"obj":"Glycan"},{"id":"T15","span":{"begin":1517,"end":1521},"obj":"Glycan"},{"id":"T16","span":{"begin":1584,"end":1593},"obj":"Glycan"},{"id":"T17","span":{"begin":1603,"end":1609},"obj":"Glycan"},{"id":"T18","span":{"begin":1610,"end":1619},"obj":"Glycan"},{"id":"T19","span":{"begin":1687,"end":1690},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A6","pred":"glycosmos_id","subj":"T6","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A8","pred":"glycosmos_id","subj":"T8","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A9","pred":"glycosmos_id","subj":"T9","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A10","pred":"glycosmos_id","subj":"T10","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A13","pred":"glycosmos_id","subj":"T13","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A14","pred":"glycosmos_id","subj":"T14","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A15","pred":"glycosmos_id","subj":"T15","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A16","pred":"glycosmos_id","subj":"T16","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A17","pred":"glycosmos_id","subj":"T17","obj":"https://glycosmos.org/glycans/show/G76685HR"},{"id":"A18","pred":"glycosmos_id","subj":"T18","obj":"https://glycosmos.org/glycans/show/G07394RV"},{"id":"A19","pred":"glycosmos_id","subj":"T19","obj":"https://glycosmos.org/glycans/show/G91237TK"},{"id":"A20","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"},{"id":"A21","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A22","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A23","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A24","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A25","pred":"image","subj":"T6","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A26","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A27","pred":"image","subj":"T8","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A28","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A29","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A30","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A31","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A32","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A33","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A34","pred":"image","subj":"T15","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"},{"id":"A35","pred":"image","subj":"T16","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A36","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR"},{"id":"A37","pred":"image","subj":"T18","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G07394RV"},{"id":"A38","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-GlycoEpitope
{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":919,"end":923},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":1038,"end":1042},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":1496,"end":1500},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T4","span":{"begin":1517,"end":1521},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0056"},{"id":"A4","pred":"glycoepitope_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
GlyCosmos15-Lectin-Jamboree
{"project":"GlyCosmos15-Lectin-Jamboree","denotations":[{"id":"T1","span":{"begin":1766,"end":1769},"obj":"Lectin"},{"id":"T2","span":{"begin":1940,"end":1943},"obj":"Lectin"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"GL_005239"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"GL_005239"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":52,"end":58},"obj":"Body_part"},{"id":"T2","span":{"begin":265,"end":271},"obj":"Body_part"},{"id":"T3","span":{"begin":445,"end":450},"obj":"Body_part"},{"id":"T5","span":{"begin":550,"end":556},"obj":"Body_part"},{"id":"T6","span":{"begin":704,"end":709},"obj":"Body_part"},{"id":"T8","span":{"begin":753,"end":759},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000019"},{"id":"A4","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0001968"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CL_0000019"},{"id":"A7","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0001968"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}
CL-cell
{"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":445,"end":450},"obj":"Cell"},{"id":"T2","span":{"begin":704,"end":709},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000019"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000019"}],"text":"Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification.\nThe developmental expression of 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid-containing glycosphingolipids (KDN-gangliosides) in rainbow trout testis during spermatogenesis was studied using a monoclonal antibody, mAb.kdn3G, which recognizes the KDN alpha 2--\u003e3Gal beta 1--\u003eepitope. A major KDN-ganglioside found in mature sperm, (KDN)GM3, KDN alpha 2--\u003e3Gal beta 1--\u003e4Glc beta 1--\u003eCer (where Cer is ceramide), was expressed in testis throughout all stages of its maturation. On the contrary, four new KDN-gangliosides which were reactive with mAb.kdn3G were not detected in mature sperm, although they were identified in immature testis and expressed during spermatogenesis. The structures of these KDN-gangliosides were established by chemical, enzymatic and immunochemical methods as: (i) (KDN)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (ii) (KDN, Neu5Ac)GD1a, KDN alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(Neu5Ac alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer and Neu5Ac alpha 2--\u003e3Gal beta 1--\u003e3GalNAc beta 1--\u003e4(KDN alpha 2--\u003e3)Gal beta 1--\u003e4Glc beta 1--\u003eCer; (iii) (KDN) GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(KDN alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer; and (iv) (KDN,Neu5Ac)GD1 alpha, KDN alpha 2--\u003e3Gal beta 1--\u003e3(Neu5Ac alpha 2--\u003e6)GalNAc beta 1--\u003e4Gal beta 1--\u003e4Glc beta 1--\u003eCer. (KDN)GD1a and (KDN,Neu5Ac)GD1a first appeared at an early stage of spermatogenesis, but (KDN)GD1 alpha and (KDN,Neu5Ac)GD1 alpha were not expressed until 2 months prior to spermiation. While (KDN)GM3 was previously shown to contain only 4-sphingenine (d18:1) acylated with a C16:0 fatty acid, the new KDN-gangliosides discovered in this study were composed of 4-hydroxysphinganine (t18:0) or 4-sphingenine (d18:1), and were acylated with a C24:1 or C16:0 fatty acid. A possible function of these KDN-gangliosides is suggested."}